Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial.

about

Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial.

Item

http://www.wikidata.org/entity/Q41014190

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety and efficacy of tamsulo ...... double-blind randomized trial.

@en

type

Item

label

Safety and efficacy of tamsulo ...... double-blind randomized trial.

@en

prefLabel

Safety and efficacy of tamsulo ...... double-blind randomized trial.

@en

P1476

Safety and efficacy of tamsulo ...... double-blind randomized trial.

@en

P2093

Ananth Janardhan Kamath

http://www.w3.org/2001/XMLSchema#string

Chikka Moga Siddaiah Manohar

http://www.w3.org/2001/XMLSchema#string

Mahadevappa Nagabhushana

http://www.w3.org/2001/XMLSchema#string

Ramachandra Pudakalkatti Sanjay

http://www.w3.org/2001/XMLSchema#string

Ramaiah Keshavamurthy

http://www.w3.org/2001/XMLSchema#string

Vilvapathy Senguttuvan Karthikeyan

http://www.w3.org/2001/XMLSchema#string

P2860

Medical therapy for benign prostatic hyperplasia: a review

Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis

A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensi

Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH.

Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis.

Non-Hormonal treatment of BPH/BOO

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.

Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

P304

148-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5173/CEJU.2017.924

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28721281

http://www.w3.org/2001/XMLSchema#string

P932

5510335

http://www.w3.org/2001/XMLSchema#string